C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2006
11/02/2006	US20060248603 Novel fibrillin-like polypeptides
11/02/2006	US20060248602 Contacting polynucleotide with acetylthiourea, N,N-dimethylthioformamide, N,N'-diphenylthiourea, N-ethylthiourea, 2-imidazolidinethione, 4(6)-methyl-2-thiouracil, N-methylthiourea, phenylthio-carbamid, 6-phenyl-2-thiouracil, 6-propyl-2-thiouracil, tetramethylthiourea, thioacetamide, thioacetanilide
11/02/2006	US20060248601 Modification of organelle metabolism by unc-51-like kinases roma1 or 2tm proteins
11/02/2006	US20060247423 Hemoglobin conjugate and the preparation method and its use
11/02/2006	US20060247422 Chemically modified G-CSF
11/02/2006	US20060247421 Liver x receptor alpha splicing mutant protein, gene thereof and utilization of the same
11/02/2006	US20060247420 Immune cell recptor ligand and immune cell receptor
11/02/2006	US20060247419 Translocation dependent complementation for drug screening
11/02/2006	US20060247418 Gfp fusion proteins and their use
11/02/2006	US20060247416 HIV gp41 HR2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
11/02/2006	US20060247224 Melanocortin receptor ligands
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	US20060247198 TGF-beta type receptor cDNAs encoded products and uses therefor
11/02/2006	US20060247196 Yeast genes that affect viral replication
11/02/2006	US20060247191 Chimeric cytoplasmic signalling molecules
11/02/2006	US20060247190 Compositions and methods for treating human papillomavirus mediated disease
11/02/2006	US20060247176 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
11/02/2006	US20060247175 Methods of predicting therapeutic efficacy of treatment of a multiple sclerosis patient
11/02/2006	US20060247173 Alpha-conotoxin peptides
11/02/2006	US20060247170 Modified growth hormones
11/02/2006	US20060247164 Meltrins
11/02/2006	US20060247160 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension
11/02/2006	US20060247157 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides
11/02/2006	US20060247154 Concanavalin a, methods of expressing, purifying and characterizing concanavalina, and sensors including the same
11/02/2006	US20060246588 Modified zinc finger binding proteins
11/02/2006	US20060246586 Chromosome-based platforms
11/02/2006	US20060246585 Nucleic acid complex and method of introducing nucleic acid into cell using the same
11/02/2006	US20060246569 Packaging systems for human recombinant adenovirus to be used in gene therapy
11/02/2006	US20060246567 Modified zinc finger binding proteins
11/02/2006	US20060246549 Peptide acceptor ligation methods
11/02/2006	US20060246548 CE7-specific redirected immune cells
11/02/2006	US20060246547 Nematode-extracted serine protease inhibitors and anticoagulant proteins
11/02/2006	US20060246544 Manufacturing process for the production of peptides grown in insect cell lines
11/02/2006	US20060246543 Slim compositions and methods of use thereof
11/02/2006	US20060246540 Monoclonal, humanized, fragmented or labeled antibodies; extracellular proteins; expression vectors; host cells
11/02/2006	US20060246539 Protein production method utilizing yebF
11/02/2006	US20060246538 Capable of sodium-independently transporting branched amino acids
11/02/2006	US20060246537 Multi-step process for the manufacture of therapeutic protein
11/02/2006	US20060246531 Chemo-enzymatic process for proteome-wide mapping of post-translational modification
11/02/2006	US20060246530 Method and reagent for the specifically identifying and quantifying one or more proteins in a sample
11/02/2006	US20060246521 Serum tumor marker in rodent prostate cancer models
11/02/2006	US20060246520 Gamma delta t cell-mediated therapy
11/02/2006	US20060246519 For use in the capture and/or purification of biotinylated proteins
11/02/2006	US20060246518 Compositions and methods for detection of sirolimus
11/02/2006	US20060246509 Unnatural reactive amino acid genetic code additions
11/02/2006	US20060246502 Screening for a material that promotes or inhibits binding between a rabconnectin-3-binding protein having a specific amino acid sequence and rabconnectin-3 and therefore would be useful for regulating Ca2+-dependent exocytosis
11/02/2006	US20060246498 HNRPLL polypeptides, polynucleotides encoding same and compositions and methods of using same
11/02/2006	US20060246491 Micro-RNA's that regulate muscle cells
11/02/2006	US20060246486 Human signal peptide-containing proteins
11/02/2006	US20060246483 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods
11/02/2006	US20060246471 Compositions and methods for screening pro-apoptotic compounds
11/02/2006	US20060246465 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/02/2006	US20060246461 Nucleotide sequence coding membrane protein; diagnosis of tumor, cancer
11/02/2006	US20060246456 Fucose transporter
11/02/2006	US20060246452 Method for identifying nucleic acid molecules associated with angiogenesis
11/02/2006	US20060246448 Inhibition of tace or amphiregulin for the modulation of egf receptor signal transactivation
11/02/2006	US20060246442 Using zinc transporter protein-8 to identify modulators for treatment and diagnosis of diabetic disorders
11/02/2006	US20060246440 Methods for producing zinc finger proteins that bind to extended dna target sequences
11/02/2006	US20060246436 Method for judging sensibility to imatinib
11/02/2006	US20060246424 Self-replicating RNA molecule from hepatitis C virus
11/02/2006	US20060246422 Methods and compositions for use in spliceosome mediated RNA trans-splicing
11/02/2006	US20060246125 Proteoliposome for use as gene transfer tool in treatment and diagnosis of cardiomyopathy, type II diabetes, Alzheimer's, Parkinson's diseases; gene therapy
11/02/2006	US20060246095 Multiepitope polypeptides for cancer immunotherapy
11/02/2006	US20060246092 Immunoprotective influenza antigen and its use in vaccination
11/02/2006	US20060246090 Vaccine against hcv
11/02/2006	US20060246089 Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis b and the producing method and use thereof
11/02/2006	US20060246088 Use of HIV-1 gp120 and gp160 proteins modified in the V3 loop for the preparation of vaccine compositions and formulations containing the same
11/02/2006	US20060246087 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration
11/02/2006	US20060246086 Virulence genes and proteins from Brucella melitensis, and their use
11/02/2006	US20060246082 Therapeutic peptides and method
11/02/2006	US20060246078 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases
11/02/2006	US20060246068 Polypeptides having a triggering NK activity and biological applications
11/02/2006	US20060246067 Immunomodulatory constructs and their uses
11/02/2006	US20060246066 Cleavable reagents for specific delivery to disease sites
11/02/2006	US20060246065 Fail molecules and uses thereof
11/02/2006	US20060246064 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab
11/02/2006	US20060246059 therapeutic protein comprising a tenth domain of fibronectin type III; protein scaffold; antibody design; scaffold derived from a fibronectin type III (Fn3) or Fn3-like domain, function like natural or engineered antibodies; antibody mimics designed for optimal folding, stability, and solubility
11/02/2006	US20060246048 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis of vision defects
11/02/2006	US20060246047 Peptide wirh apoptosis-inhibiting activity
11/02/2006	US20060246046 Modified tridegins, production and use thereof as transglutaminase inihibitors
11/02/2006	US20060246039 Growth differentiation factor-7
11/02/2006	US20060246034 Interferon-beta composite
11/02/2006	US20060246032 Chimeric IL-10
11/02/2006	US20060246024 Method for stimulating hair follicle cell proliferation
11/02/2006	EP1717316A1 Interferon-like protein ZCYTO21
11/02/2006	EP1717315A2 Osteoprotegerin binding proteins and receptors
11/02/2006	EP1717314A1 Receptor for modified low-density lipoprotein
11/02/2006	EP1717249A1 Peptides containing a cholesterol recognition sequence and their uses
11/02/2006	EP1717248A1 Tumor targeted vector
11/02/2006	EP1717247A1 Cyclic peptides binding to the somatostatin receptor
11/02/2006	EP1717246A1 Tnf antagonists and tnf inhibitors comprising the same as the active ingredient
11/02/2006	EP1717245A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
11/02/2006	EP1717244A1 Akt activity specifically inhibiting polypeptide
11/02/2006	EP1716869A1 Drug for preventing or treating heart diseases comprising cd9 gene
11/02/2006	EP1716858A2 Oncolytic virus
11/02/2006	EP1716752A1 MyoD88-knockout mouse as a model animal unresponsive to bacterial cell wall components
11/02/2006	EP1716419A2 Method for the detection of autoantibodies against specific peptides and its use in diagnosis and treatment of pregnancy-loss or infertility.
11/02/2006	EP1716256A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
11/02/2006	EP1716244A2 H. pylori fucosyltransferases
11/02/2006	EP1716237A1 Orotate transporter encoding marker genes

1 ... 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 ... 2916